BioPhoT seminar: From Hit Compound to Clinical Trials

​Join us for a special knowledge and experience sharing event focused on commercialisation of drug discovery projects.

​Lector: Dr. Scott L. Dax
With 25+ years of experience in pharmaceutical R&D leadership, Dr. Dax has held senior roles within large pharma (Johnson & Johnson) and biotech firms. He was Chief Scientific Officer at CerSci Therapeutics, which was acquired by Acadia Pharmaceuticals in 2020.

​Event Program:

​09:50 – 10:00 Arrival

​10:00 – 10:05 Introduction

​10:05– 10:50 Keynote by Scott L. Dax

​10:50 – 11:25 Fireside discussion and Q&A

​11:25 – 12:00+ Networking and discussions

​Event is funded by Long-term State Research Program project BioPhoT-research platform for innovative products in biomedicine and photonics (IVPP-EM-Inovācija-2024/1-0002)